GlassScriptPhysician profile
Ann E Johnson
NPI 1710973680
$475.23
in general payments reported to CMS, 2019-2025
11 companies · $81.55 in 2025
The $81.55 reported for 2025 was less than what a typical Women'S Health (Nurse Practitioner) provider received nationally (typical 2025 total: $123).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $79.76 · 2022: $199 · 2023: $58.17 · 2024: $56.40 · 2025: $81.55.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $196.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $196.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $106.14 | 2022 | |
| Organon LLC | $87.79 | 2021-2025 | Nexplanon |
| Astellas Pharma US INC | $74.35 | 2023-2024 | Veozah |
| Abbvie INC. | $59.04 | 2021-2022 | |
| Becton, Dickinson and Company | $39.67 | 2022 | |
| Biogen, INC. | $28.13 | 2025 | Zurzuvae |
| Hologic Sales and Service, LLC | $23.75 | 2025 | Aptima, Thinprep 2000 Processor |
| Pfizer INC. | $16.25 | 2023 | |
| Exeltis, USA INC. | $14.51 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $13.22 | 2021 | |
| Scynexis, INC. | $12.38 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ann Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.